These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8578539)

  • 21. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL; Babior BM
    Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mode of action of vitamin K in stimulating prothrombin synthesis.
    Olson RE; Li LF; Philipps G; Kipfer RK
    Thromb Diath Haemorrh; 1968 Jul; 19(3):611-2. PubMed ID: 5708144
    [No Abstract]   [Full Text] [Related]  

  • 24. Nature of the vitamin K-dependent CO2 fixation in microsomal membranes.
    Houser RM; Searcey MT; Gardner EJ; Scheinbuks J; Subba Rao GN; Jones JP; Hall AL
    Fed Proc; 1978 Oct; 37(12):2610-4. PubMed ID: 700170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of clotting factors by the isolated perfused rat liver.
    Olson JP; Miller LL; Troup SB
    J Clin Invest; 1966 May; 45(5):690-701. PubMed ID: 5935358
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P; Stark PY; Johnson RL; Bell RG
    J Pharmacol Exp Ther; 1977 Jun; 201(3):541-6. PubMed ID: 864593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.
    Vainieri H; Wingard LB
    J Pharmacol Exp Ther; 1977 May; 201(2):507-17. PubMed ID: 870684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat factor X is synthesized as a single chain precursor inducible by prothrombin fragments.
    Graves CB; Munns TW; Willingham AK; Strauss AW
    J Biol Chem; 1982 Nov; 257(21):13108-13. PubMed ID: 7130196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin-induced accumulation of vitamin K-dependent proteins. Comparison between hepatic and non-hepatic tissues.
    Roncaglioni MC; Soute BA; de Boer-vd Berg MA; Vermeer C
    Biochem Biophys Res Commun; 1983 Aug; 114(3):991-7. PubMed ID: 6684427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in the study of the vitamin K-dependent carboxylation system.
    Olson RE
    World Rev Nutr Diet; 1978; 31():216-25. PubMed ID: 735138
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
    Walz DA; Kipfer RK; Olson RE
    J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by warfarin enantiomers of prothrombin synthesis, protein carboxylation, and the regeneration of vitamin K from vitamin K epoxide.
    Bell RG; Ren P
    Biochem Pharmacol; 1981 Jul; 30(14):1953-8. PubMed ID: 7271884
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral anticoagulant therapy: the biosynthetic basis.
    Suttie JW
    Semin Hematol; 1977 Jul; 14(3):365-74. PubMed ID: 877599
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of vitamin K-dependent carboxylase activity in lung type II cells but not in lung macrophages.
    Wallin R; Rannels SR
    Biochem J; 1988 Mar; 250(2):557-63. PubMed ID: 3355538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of clotting factors by a cell-free system from rat liver in response to the addition of vitamin K1 in vitro.
    Lowenthal J; Jaeger V
    Biochem Biophys Res Commun; 1977 Jan; 74(1):25-32. PubMed ID: 402132
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide.
    Camire RM; Larson PJ; Stafford DW; High KA
    Biochemistry; 2000 Nov; 39(46):14322-9. PubMed ID: 11087381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of vitamin K: demonstration of a liver precursor of prothrombin.
    Suttie JW
    Science; 1973 Jan; 179(4069):192-4. PubMed ID: 4682251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dioxygen and the vitamin K-dependent synthesis of prothrombin.
    Esnouf MP; Green MR; Hill HA; Irvine GB; Walter SJ
    Ciba Found Symp; 1978 Jun 6-8; (65):187-97. PubMed ID: 225139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.